离子交换与吸附

1 Levin A,Stevens P E.Early detection of CKD:The benefits,limitations an deffects on prognosis[J].Nature Reviews Nephrology,2011,7(8):446-457.

2 Chen W,Zheng R,Zeng H,et al.Epidemiology of lung cancer in C hina[J].Thoracic Cancer,2015,6(2):209-215.

3 Barta J A,Powell C A,Wisnivesky J P.Global epidemiology of lung cancer[J].Annals of Global Health,2019,85(1):8.

4 Subramanian J,Govindan R.Lung cancer in never smokers:A review[J].Journal of Clinical Oncology,2007,25(5):561-570.

5 Blackhall F V T,Devita S,Hellman S A.Rosenberg (Eds.),cancer:Principles and practice of oncology,seventh edition[J].Surgical Oncology,2006,14(4):195.

6 Honig L S,Vellas B,Woodward M,et al.Trial of solanezumab for mild dementia due to Alzheimer’s disease[J].New England Journal of Medicine,2018,378 (4):321-330.

7 None.The need for early detection and treatment in Alzheimer’s disease[J].EBio Medicine,2016,9:1-2.

8 Maliszewska-Cyna E,Lynch M,Jordan O J,et al.The benefits of exercise and metabolic interventions for the prevention and early treatment of Alzheimer’s disease[J].Current Alzheimer Research,2017,14(1):47-60.

9 Richardet E,Villavicencio R,Hernandez P A,et al.P1.09:Delays in the diagnosis and treatment of lung cancer[J].Journal of Thoracic Oncology,2016,11(10):S185.

10 Ghosh R K,Pandey T,Dey P.Liquid biopsy:A new avenue in pathology[J].Cytopathology,2019,30 (2):138-143.

11 Petsko G A,Ringe D.Protein structure and function[M].Washington:New Science Press,2004.

12 Hanash S.Disease proteomics[J].Nature,2003,422(6928):226-232.

13 Drabovich A P,Martínez-Morillo E,Diamandis E P.Toward an integrated pipeline for protein biomarker development[J].Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics,2015,1854(6):677-686.

14 Waikar S S,Betensky R A,Emerson S C,et al.Imperfect gold standards for kidney injury biomarker evaluation[J].Journal of the American Society of Nephrology,2012,23(1):13-21.

15 Engvall E,Perlmann P.Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G[J].Immunochemistry,1971,8(9):871-874.

16 Yalow R S,Berson S A.Immunoassay of endogenous plasma insulin in man[J].Journal of Clinical Investigation,1960,39(6):1157-1175.

17 Luppa P B,Sokoll L J,Chan D W.Immunosensors:Principles and applications to clinical chemistry[J].Clinica chimica acta,2001,314(1/2):1-26.

18 Aebersold R,Mann M.Mass spectrometry-based proteomics[J].Nature,2003,422(6928):198-207.

19 Bange A,Halsall H B,Heineman W R.Microfluidic immunosensor systems[J].Biosensors and Bioelectronics,2005,20(12):2488-2503.

20 Templin M F,Stoll D,Schrenk M,et al.Protein microarray technology[J].TRENDS in Biotechnology,2002,20(4):160-166.

21 Yang X,Tang Y,Alt R R,et al.Emerging techniques for ultrasensitive protein analysis[J].The Analyst,2016,141(12):3473-3481.

22 Hu R,Sou K,Takeoka S.A rapid and highly sensitive biomarker detection platform based on a temperatureresponsive liposome-linked immunosorbent assay[J].Scientific Reports,2020,10(1):18086.

23 Cardozo K H M,Lebkuchen A,Okai G G,et al.Establishing a mass spectrometry-based system for rapid detection of SARS-Co V-2 in large clinical sample cohorts[J].Nature Communications,2020,11(1):6201.

24 Higashi S,Yagyu K,Nagase H,et al.Ultra-high-speed western blot with the aid of immunoreaction enhancing technology[J].Journal of visualized experiments:Jo VE,2020(163):e61657.

25 Naylor S.Biomarkers:Current perspectives and future prospects[J].Expert Review of Molecular Diagnostics,2003,3(5):525-529.

26 Mayeux R.Biomarkers:Potential uses and limitations[J].Neuro Rx,2004,1:182-188.

27 Gunn G R,Evans C,Yang E.Immunogenicity and biomarkers:Bioanalytical challenges and considerations[J].Bioanalysis,2017,9(22):1729-1732.

28 Yang S Y,Chiu M J,Chen T F,et al.Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases[J].Scientific Reports,2017,7(1):9304.

29 Andreasson U,Blennow K,Zetterberg H.Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders[J].Alzheimer’s&Dementia:Diagnosis,Assessment&Disease Monitoring,2016,3(1):98-102.

30 Pallares R M,Su X,Lim S H,et al.Fine-tuning of gold nanorod dimensions and plasmonic properties using the Hofmeister effects[J].Journal of Materials Chemistry C,2016,4(1):53-61.

31 Sun J,Sun H,Liang Z.Nanomaterials in electrochemiluminescence sensors[J].Chem Electro Chem,2017,4(7):1651-1662.

32 Oh E S,Mielke M M,Rosenberg P B,et al.Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma[J].Journal of Alzheimer’s Disease,2010,21(3):769-773.

33 Chen H,Jiang C,Yu C,et al.Protein chips and nanomaterials for application in tumor marker immunoassays[J].Biosensors and Bioelectronics,2009,24(12):3399-3411.

34 Dinish U S,Beffara F,Humbert G,et al.Surface‐enhanced Raman scattering‐active photonic crystal fiber probe:Towards next generation liquid biopsy sensor with ultra high sensitivity[J].Journal of Biophotonics,2019,12(11):e201900027.

35 Gorodkiewicz E,Lukaszewski Z.Recent progress in surface plasmon resonance biosensors (2016 to Mid-2018)[J].Biosensors,2018,8(4):132.

36 Wang J,Lin W,Cao E,et al.Surface plasmon resonance sensors on Raman and fluorescence spectroscopy[J].Sensors,2017,17(12):2719.

37 Hu W,Chen H,Shi Z,et al.Dual signal amplification of surface plasmon resonance imaging for sensitive immunoassay of tumor marker[J].Analytical Biochemistry,2014,453:16-21.

38 Murphy M P,Levine I H.Alzheimer’s disease and the amyloid-β peptide[J].Journal of Alzheimer’s Disease,2010,19(1):311-323.

39 Conti S,Bonazzi S,Laiacona M,et al.Montreal cognitive assessment (Mo CA)-italian version:Regression based norms and equivalent scores[J].Neurological Sciences,2015,36(2):209-214.

40 Ercoli L M,Siddarth P,Dunkin J J,et al.MMSE items predict cognitive decline in persons with genetic risk for Alzheimer’s disease[J].Journal of geriatric psychiatry and neurology,2003,16(2):67-73.

41 Ferreira L K,Busatto G F.Neuroimaging in Alzheimer’s disease:Current role in clinical practice and potential future applications[J].Clinics,2011,66:19-24.

42 Chan H N,Xu D,Ho S L,et al.Ultra-sensitive detection of protein biomarkers for diagnosis of Alzheimer's disease[J].Chemical Science,2017,8(5):4012-4018.

43?zcan N,Medetalibeyoglu H,Aky?ld?r?m O,et al.Electrochemical detection of amyloid-β protein by delaminated titanium carbide MXene/multi-walled carbon nanotubes composite with molecularly imprinted polymer[J].Materials Today Communications,2020,23:101097.

44 Kew M.Alpha-fetoprotein in primary liver cancer and other diseases[J].Gut,1974,15(10):814-821.

45 Yang H,Zhao C,Li R,et al.Noninvasive and prospective diagnosis of coronary heart disease with urine using surface-enhanced Raman spectroscopy[J].The Analyst,2018,143(10):2235-2242.

46 Zhao L J,Yu R J,Ma W,et al.Sensitive detection of protein biomarkers using silver nanoparticles enhanced immunofluorescence assay[J].Theranostics,2017,7(4):876-883.

47 Wang C F,Wang Z G,Sun X Y,et al.An ultrasensitive fluorescent aptasensor for detection of cancer marker proteins based on graphene oxide-ss DNA[J].RSC Advances,2018,8(72):41143-41149.

48 Cha M K,Suh K H,Kim I H.Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma[J].Journal of Experimental&Clinical Cancer Research,2009,28(1):93.

49 Park B J,Cha M K,Kim I H.Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses[J].BMC Research Notes,2014,7(1):7.

50 Ebeling F G,Stieber P,Untch M,et al.Serum CEA and CA 15-3 as prognostic factors in primary breast cancer[J].British Journal of Cancer,2002,86(8):1217-1222.

51 Molina R,Jo J,Filella X,et al.C-erb B-2 oncoprotein,CEA,and CA 15.3 in patients with breast cancer:Prognostic value[J].Breast Cancer Research and Treatment,1998,51(2):109-119.

52 Lee M J,Lee E S,Kim T H,et al.Detection of thioredoxin-1 using ultra-sensitive ELISA with enzymeencapsulated human serum albumin nanoparticle[J].Nano Convergence,2019,6(1):37.

53 Hakimian F,Ghourchian H.Ultrasensitive electrochemical biosensor for detection of micro RNA-155 as a breast cancer risk factor[J].Analytica Chimica Acta,2020,1136:1-8.

54 Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA:A Cancer Journal for Clinicians,2018,68(6):394-424.

55 Todua F,Gagua R,Maglakelidze M,et al.Cancer incidence and mortality-Major patterns in GLOBOCAN 2012,worldwide and Georgia[J].Bull Georg Natl Acad Sci,2015,9(1):168-173.

56 Martini G,Troiani T,Cardone C,et al.Present and future of metastatic colorectal cancer treatment:A review of new candidate targets[J].World Journal of Gastroenterology,2017,23(26):4675.

57 Siegel R L,Miller K D,Fedewa S A,et al.Colorectal cancer statistics,2017[J].CA:A Cancer Journal for Clinicians,2017,67(3):177-193.

58 Arnold M,Sierra M S,Laversanne M,et al.Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2017,66(4):683-691.

59 Romani P,Ignesti M,Gargiulo G,et al.Extracellular NME proteins:A player or a bystander?[J].Laboratory Investigation,2018,98(2):248-257.

60 Lu Y,Liu Q,Fu B,et al.Label-free MIP-SERS biosensor for sensitive detection of colorectal cancer biomarker[J].Talanta,2023,258:124461.

61 Yao M M,Tang H,Yin Y C,et al.Tuning the surface enhanced Raman spectroscopy performance of Au core-Ag shell nanostructure for label-free highly sensitive detection of colorectal cancer marker[J].Journal of Alloys and Compounds,2022,896:163043.

62 Zhang X,Gan T,Xu Z,et al.Immune-like sandwich multiple hotspots SERS biosensor for ultrasensitive detection of NDKA biomarker in serum[J].Talanta,2024,271:125630.

63 Geurts S M E,De-Vegt F,Van-Altena A M,et al.Considering early detection of relapsed ovarian cancer:A review of the literature[J].International Journal of Gynecological Cancer,2011,21(5):837-845.

64 Zhu C S,Pinsky P F,Cramer D W,et al.A Framework for evaluating biomarkers for early detection:Validation of biomarker panels for ovarian cancer[J].Cancer Prevention Research,2011,4(3):375-383.

65 Peng N J,Liou W S,Liu R S,et al.Early detection of recurrent ovarian cancer in patients with low-level increases in serum CA-125 levels by 2-[F-18]fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography[J].Cancer Biotherapy and Radiopharmaceuticals,2011,26(2):175-181.

66 Cramer D W,Bast R C,Berg C D,et al.Ovarian cancer biomarker performance in prostate,lung,colorectal,and ovarian cancer screening trial specimens[J].Cancer Prevention Research,2011,4(3):365-374.

67 Viswanathan S,Rani C,Ribeiro S,et al.Molecular imprinted nanoelectrodes for ultra sensitive detection of ovarian cancer marker[J].Biosensors and Bioelectronics,2012,33(1):179-183.

68 Viswanathan S,Rani C,Delerue-Matos C.Ultrasensitive detection of ovarian cancer marker using immunoliposomes and gold nanoelectrodes[J].Analytica Chimica Acta,2012,726:79-84.

69 Sproston N R,Ashworth J J.Role of C-reactive protein at sites of inflammation and infection[J].Frontiers in Immunology,2018,9:754.

70 Reitz C,Berger K,De-Maat M P M,et al.CRP gene haplotypes,serum CRP,and cerebral small-vessel disease:The rotterdam scan study and the MEMO study[J].Stroke,2007,38(8):2356-2359.

71 Yanbaeva D G,Dentener M A,Spruit M A,et al.IL6 and CRPhaplotypes are associated with COPD risk and systemic inflammation:A case-control study[J].BMC Medical Genetics,2009,10(1):23.

72 Zhang P,Bao Y,Draz M,et al.Rapid and quantitative detection of C-reactive protein based on quantum dots and immunofiltration assay[J].International Journal of Nanomedicine,2015:6161.

73 Biondi M,D’Alessandro P.Genus-group names of Afrotropical flea beetles (Coleoptera:Chrysomelidae:Alticinae):Annotated catalogue and biogeographical notes[J].European Journal of Entomology,2010,107(3):401-424.

74 Luo Y,Zhang B,Chen M,et al.Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay[J].Journal of Translational Medicine,2012,10(1):24.

75 Gupta P K,Son S E,Seong G H.Functionalized ultra-fine bimetallic Pt Ru alloy nanoparticle with high peroxidasemimicking activity for rapid and sensitive colorimetric quantification of C-reactive protein[J].Microchimica Acta,2021,188(4):119.

76 Hu Z,Zhou X,Duan J,et al.Aptamer-based novel Ag-coated magnetic recognition and SERS nanotags with interior nanogap biosensor for ultrasensitive detection of protein biomarker[J].Sensors and Actuators B:Chemical,2021,334:129640.

77 Ali G K,Omer K M.Ultrasensitive aptamer-functionalized Cu-MOF fluorescent nanozyme as an optical biosensor for detection of C-reactive protein[J].Analytical Biochemistry,2022,658:114928.

78 Butcher K S,Parsons M W.Cardiac enzyme elevations after stroke:The importance of specificity[J].Stroke,2002,33(8):1944-1945.

79 Katus H A,Remppis A,Neumann F J,et al.Diagnostic efficiency of troponin T measurements in acute myocardial infarction[J].Circulation,1991,83(3):902-912.

80 Munje R D,Jacobs M,Muthukumar S,et al.A novel approach for electrical tuning of nano-textured zinc oxide surfaces for ultra-sensitive troponin-T detection[J].Analytical Methods,2015,7(24):10136-10144.

81 Akanda M R,Aziz M A,Jo K,et al.Optimization of phosphatase-and redox cycling-based immunosensors and Its application to ultrasensitive detection of troponin I[J].Analytical Chemistry,2011,83(10):3926-3933.

82 Diware M S,Cho H M,Chegal W,et al.Ultrasensitive,label-free detection of cardiac biomarkers with optical SISsensor[J].Biosensors and Bioelectronics,2017,87:242-248.